Skip to Content
MayoACCESS
MayoLINK
Register
My Dashboard
Test Catalog
Algorithms
Download Test Catalog & Interpretive Handbook
New Tests
NY State Informed Consent Tests
Performing Locations
Referred Tests
Specialty Testing
Test Updates
Ordering & Results
Critical Values & Results
Custom Gene Ordering
Forms
LIS Resources
MayoACCESS Resources
MayoLINK Resources
Order Your First Test
Patient Information and Signature Forms
Request Additional Testing
Send Additional Specimen
Specimen Handling
Collection & Preparation
Dangerous Goods Training
Shipping & Courier Guides
Shipping Regulations
Supplies
Customer Service
Billing
Contact Us
FAQ
IT Updates
Operational Updates
Quality & Compliance
Education & Insights
Educational Resources
News
Outreach
Podcasts
Stories
Contact
Log Out
Return to Answers From the Lab
Laboratory Perspective of COVID-19: Aimee Boerger and Emily Fernholz
By
Melissa Peterson
• August 25, 2020
Share this:
Related Episodes
How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.
By
Sarah Jarvis
•
July 3, 2025
Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D.
By
Samantha Rossi
•
July 1, 2025
Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.
By
Samantha Rossi
•
June 24, 2025
Melissa Peterson
Related Posts
How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.
Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D.
Neurodegenerative Diseases: Diagnostic Advancements
